Vertex Pharmaceuticals (MA) Announces Retirement Of Peter Mueller, Ph.D.
Published: Jul 10, 2014
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Peter Mueller, Ph.D., Executive Vice President of Global Research and Development and Chief Scientific Officer, will retire after more than 10 years with the company. Dr. Mueller’s retirement will be effective October 31, 2014, following a planned transition period. Dr. Mueller joined Vertex in 2003 as Chief Scientific Officer and Senior Vice President, Drug Discovery and Innovation.
Help employers find you! Check out all the jobs and post your resume.